Navigation Links
Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo

eth and Solvay Pharmaceuticals as well as co-developed and co-commercialized by the two companies.

About Schizophrenia

Schizophrenia is a chronic form of psychosis that affects approximately 1.1 percent of the population in the United States in one year. It is characterized by positive and negative symptoms such as hallucinations, delusions, poverty of speech, disorganized thought and emotional blunting. Severity of the symptoms and the long-term pattern of schizophrenia often cause a high degree of disability for patients and place a burden on families, caregivers and communities.

While atypical antipsychotics help reduce positive and negative symptoms to varying degrees, some may be associated with weight gain, glucose and triglyceride elevations, and altered lipids, which may increase the risk of diabetes and heart disease. These side effects are compounded by the fact that individuals with schizophrenia are more likely than the general population to be overweight or obese, and they have a higher risk of diabetes than the general population.

About Wyeth Pharmaceuticals

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements based on current expectations of future events and are subject to risks
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Managing Preanalytical Processes for Patient Safety
2. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
3. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
6. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
7. Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) in Patients with Type 2 Diabetes
8. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
9. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
10. Enbrel Safety Data for up to Eight Years in Patients with Juvenile Rheumatoid Arthritis Being Presented at EULAR
11. Repros Reports That Proellex Has Demonstrated Superior Efficacy and Safety in Endometriosis When Compared to Standard of Drug Care
Post Your Comments:
(Date:8/21/2008)...d EMERYVILLE, Calif., Aug. 21 /PRNewswire-FirstCal...nyx Pharmaceuticals, Inc.,(Nasdaq: ONXX ) today a...ts,in the STORM Sorafenib as Adjuvant Treatment in...rcinoma trial. The randomized, double-blind,place...R) (sorafenib),tablets as adjuvant treatment, whic...
(Date:8/20/2008)... 20 /- Enobia Pharma, an emerging bio...ics for serious bone,disorders, today announced th...ypophosphatasia has been dosed. Enobia is investig...40 for the treatment of this rare and,often crippl...proved,treatment., Under two separate protocols, ...
(Date:8/19/2008)...lia, Aug. 20 /Xinhua--,Phar...SL) today announced,that the Phase 3 clinical tria... subjects with bronchiectasis has concluded with n...llowing 12 months of treatment., A total of 123 s...wice,per day and 99 subjects completed the full 12...
(Date:8/19/2008)...nd tissue samples to be used to identify molecular...ss., Aug. 19 /PRNewswire-USNewswire/ -- ALS Therap...the acceleration of an ALS,biomarker effort using ...k,of clinical partnerships. These ongoing projects...ndentify the altered expression of genes,and prote...
Breaking Medicine Technology:Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 2Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 3Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 4Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 5Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia 2Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia 312 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis 212 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis 3ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 2ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 3HIV Drugs Linked to Increased Risk of Heart Attack 15747 1HIV Drugs Linked to Increased Risk of Heart Attack 15747 2HIV Drugs Linked to Increased Risk of Heart Attack 15747 3Sonic Innovations Celebrates 10 Year Anniversary 15745 1Sonic Innovations Celebrates 10 Year Anniversary 15745 2Sonic Innovations Celebrates 10 Year Anniversary 15745 3Genoptix Announces 2008 Annual Stockholders Meeting and Date of Record 15743 1AMERIGROUP Successful Bidder in DC RFP 15741 1AMERIGROUP Successful Bidder in DC RFP 15741 2
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
... has offered invaluable advice to women of childbe...ultivitamin daily, to cut the risks of delivering ...has indicated that by being regular with intake of...ny severe birth defects can be offset. The defects...
...dents are unprepared for skilled prescribing, warn...ribing in the UK is abundant, write Jeffrey Aronso... underprescribed and prescription errors are commo...ork in hospitals. The reasons for these errors a...
...etes in pregnancy has increased four times among A...cerns that gestational diabetes// may cause proble...ent in the last five years. Diabetes Australia NSW...a dangerous precedent. "In just five years we hav...
...University of South Florida College of Medicine sa... Florida is discouraging medical students// from o...alization. The situation means that many people do...Deutsch, MD, lead author of the study and chief re...
Other Medicine News:Health News:Many Medical Students Unprepared for Skilled Prescribing 2Health News:Malpractice Worry Discouraging Medical Students From Taking Up Obstetrics And Gynecology 2
3D Cranial is the most widely used surgical navigation software. Navigate with confidence and ease with displayed Zone of Accuracy and several fully automated features. 3D Cranial offers seamless int
The D185 is the only stimulator with FDA clearance for this application. The D185 allows transcranial motor evoked potentials to be used in surgical procedures such as scoliosis correction, spinal tu
Designed for the effective positioning of patients during spinal surgery, the frame gives the surgeon a remarkably simple and versatile surgical tool.
The Wilson Plus Radiolucent Wilson Frame delivers unrestricted radiolucency and C-arm integration with a convenient and stable method of maintaining patients in a flexed position for laminectomy, dec
Medicine Products: